Overcoming resistance to PARP inhibitor in epithelial ovarian cancer, are we ready?

Q: How does OCRA curate its research paper database?

OCRA indexes peer-reviewed papers from PubMed and CrossRef, enriched with MeSH terms, author profiles, and citation metrics. Papers are categorized by cancer type, research method, and clinical relevance.

Q: Can I search papers by MeSH term or author?

Yes. Use the search bar to filter papers by MeSH term, author name, journal, keyword, or cancer type. Each paper includes linked MeSH terms and author profiles for further exploration.

Q: How current is the paper database?

The database is updated regularly through automated ingestion from PubMed and CrossRef. Most papers appear within days of their PubMed indexing date.

doi:10.1016/j.ebiom.2020.103046

Overcoming resistance to PARP inhibitor in epithelial ovarian cancer, are we ready?

Isabelle Ray-Coquard & Olivier Tredan et al. · 2020-10-07

Links

DOI PubMed

Journal

eBioMedicine

Authors

Isabelle Ray-Coquard, Hélène Vanacker, Olivia Le Saux, Olivier Tredan

Funding

AstraZeneca France Funding Sandoz Funding Pfizer Funding Daiichi Sankyo Company Funding Novartis Funding British Microcirculation Society Funding Astellas Pharma Funding Meso Scale Diagnostics Funding Roche Funding GlaxoSmithKline Australia Funding